Insulin-activated Akt rescues Aβ oxidative stress-induced cell death by orchestrating molecular trafficking

Aging Cell

Volumn 10, Issue 5, 2011, Pages 832-843

  Picone, Pasquale ^a,b   Giacomazza, Daniela ^c   Vetri, Valeria ^b   Carrotta, Rita ^c   Militello, Valeria ^b   San Biagio, Pier Luigi ^c   di Carlo, Marta ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c CNR   (Italy)

Author keywords

Akt; Amyloid beta; Apoptosis; Cell survival; Insulin; Mitochondrion

Indexed keywords

AMYLOID BETA PROTEIN; HEXOKINASE; INSULIN; INSULIN RECEPTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BAD; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHRL1;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL DEATH; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 80052800916     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2011.00724.x     Document Type: Article

References (57)

1. Baskin DG, Porte Jr D, Guest K, Dorsa DM (1983a) Regional concentrations of insulin in the rat brain. Endocrinology 112, 898-903.
2. Baskin DG, Woods SC, West DB, van Houten M, Posner BI, Dorsa DM, Porte Jr D (1983b) Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinalfluid. Endocrinology 113, 1818-1825.
3. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11, 107-111.
4. Baskin DG, Sipols AJ, Schwartz MW, White MF (1993) Immunocytochemical detection of insulin-receptor substrate-1 (IRS-1) in rat-brain-colocalization with phosphotyrosine. Regul. Pept. 48, 257-266.
5. Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF (2001) Insulin-receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 134, 1952-1955.
6. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
7. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58, 495-505.
8. Biddinger SB, Kahn CR (2006) From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 128-158.
9. Biggs III WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 96, 7421-7426.
10. Bijur GN, Jope RS (2003) Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J. Neurochem. 87, 1427-1435.
11. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
12. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015.
13. Burgering BM, Medema RH (2003) Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73, 689-701.
14. Calnan DR, Brunet A (2008) The FoxO code. Oncogene 27, 2276-2288.
15. Carrotta R, Di Carlo M, Manno M, Montana G, Picone P, Romancino D, San Biagio PL (2006) Toxicity of recombinant beta-amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus. FASEB J. 20, 1916-1927.
16. Cheng HL, Feldman EL (1998) Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J. Biol. Chem. 23, 14560-14565.
17. Chiribau CB, Cheng L, Cucoranu IC, Yu Y-S, Clempus RE, Sorescu D (2008) FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J. Biol. Chem. 283, 8211-8217.
18. Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3, 169-178.
19. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
20. Davila D, Torres-Aleman I (2008) Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol. Biol. Cell 19, 2014-2025.
21. De Felice FG, Vieira MNN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao W-Q, Ferreira ST, Klein WL (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl Acad. Sci. USA 106, 1971-1976.
22. Di Carlo M, Picone P, Carrotta R, Giacomazza D, San Biagio PL (2010) Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation. J. Biomed. Biotechnol. 2010, art. #147835.
23. Dore S, Kar S, Quirion R (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl Acad. Sci. USA 94, 4772-4777.
24. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
25. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665.
26. Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162, 613-622.
27. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer's disease-affected brain: presence of oligomeric Abeta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100, 10417-10422.
28. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410-7425.
29. van der Heide LP, Hoekman MF, Smidt MP (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380, 297-309.
30. Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272, 19547-19553.
31. Kang S, Song J, Kang H, Kim S, Lee Y, Park D (2003) Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells. Eur. J. Endocrinol. 148, 147-155.
32. Kao SY (2009) Rescue of alpha-synuclein cytotoxicity by insulin like growth factors. Biochem. Biophys. Res. Commun. 385, 434-438.
33. Klein WL, Stine Jr WB, Teplow DB (2004) Small assemblies of unmodified amyloid beta-proteins are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging 25, 569-580.
34. Kennedy SG, Kandel ES, Cross TK, Hay N (1999) Akt inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19, 5800-5810.
35. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from A-beta 1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. U S A 95, 6448-6453.
36. Lee H-K, Kumar P, Fu Q, Rosen KM, Querfurth HW (2009) The Insulin/Akt signaling pathway is targeted by intracellular b-amyloid. Mol. Biol. Cell 20, 1533-1544.
37. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villén J, Becker EB, Di Bacco S, de la Iglesia N, Gygi S, Blackwell TK, Bonni A (2006) A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125, 987-1001.
38. Magrané J, Rosen KM, Smith RC, Walsh K, Gouras CK, Querfurth HW (2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 25, 10960-10969.
39. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Navdeep S, Chandel NS, Thompson CB, Robey RB, Hay N (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16, 819-830.
40. Miyamoto S, Murphy AN, Brown JH (2008) Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 15, 521-529.
41. de la Monte SM, Tong M, Lester-Coll N, Plater Jr M, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J. Alzheimers Dis. 10, 89-109.
42. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J. Alzheimers Dis. 16, 741-761.
43. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta 1802, 212-220.
44. Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, Perry G (2006) Oxidative damage to RNA in neurodegenerative diseases. J. Biomed. Biotechnol. 2006, art. # 82323.
45. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140.
46. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, La Ferla FM (2006) Temporal profile of amyloid-beta (A beta) oligomerization in an in vivo model of Alzheimer disease - a link between A beta and tau pathology. J. Biol. Chem. 281, 1599-1604.
47. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
48. Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M (2007) Mitochondria and neurodegeneration. Biosci. Rep. 27, 87-104.
49. Picone P, Carrotta R, Montana G, Nobile MR, San Biagio PL, Di Carlo M (2009) Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Biophys. J. 96, 4200-4211.
50. Reddy PH (2006) Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 96, 1-13.
51. Roy SK, Srivastava RK, Shankar S (2010) Inhibition of PIK3/Akt and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J. Mol. Signal. 5, 10-13.
52. Schmitt HP (2005a) On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease. Med. Hypotheses 65, 259-265.
53. Schmitt HP (2005b) Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease Psychopharmacology 179, 151-153.
54. Serrano F, Klann E (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 3, 431-443.
55. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y (2005) JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 170, 295-304.
56. Wei W, Wang X, Kusiak JW (2002) Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277, 17649-17656.
57. Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 177, 125-134.